Advancing Cancer Therapy Predictions with Patient-Derived Organoid Models of Metastatic Breast Cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Tübingen, Universität Tübingen, Dissertation, 2024
- Keyword
-
Krebs
Metastase
Brustkrebs
Therapie
Brustkrebs ; Metastase ; Pleuraerguss ; Ascites ; Therapie ; Individualisierte Medizin ; Zellkultur
- Event
-
Veröffentlichung
- (where)
-
Tübingen
- (who)
-
Universitätsbibliothek Tübingen
- (when)
-
2025
- Creator
- Contributor
-
Feil, Robert
- URN
-
urn:nbn:de:bsz:21-dspace-1612080
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Önder, Cansu Ebru
- Feil, Robert
- Universitätsbibliothek Tübingen
Time of origin
- 2025
Other Objects (12)
Advancing cancer research through organoid technology
Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells
Stratifying esophago-gastric cancer treatment using a patient-derived organoid-based threshold
The application of patient-derived organoid in the research of lung cancer
Establishment of experimental salivary gland cancer models using organoid culture and patient-derived xenografting
Screening drug effects in patient‐derived cancer cells links organoid responses to genome alterations
Screening drug effects in patient‐derived cancer cells links organoid responses to genome alterations
Cancer research using organoid technology
Cancer research using organoid technology
A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions
Role of immune-checkpoint LAG3 as a biomarker finding tool in patient-derived organoid cultures of breast cancer
Patient-derived organoid (PDO) platforms to facilitate clinical decision making
Advancing cancer research through organoid technology
Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells
Stratifying esophago-gastric cancer treatment using a patient-derived organoid-based threshold
The application of patient-derived organoid in the research of lung cancer
Establishment of experimental salivary gland cancer models using organoid culture and patient-derived xenografting
Screening drug effects in patient‐derived cancer cells links organoid responses to genome alterations
Screening drug effects in patient‐derived cancer cells links organoid responses to genome alterations
Cancer research using organoid technology
Cancer research using organoid technology
A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions
Role of immune-checkpoint LAG3 as a biomarker finding tool in patient-derived organoid cultures of breast cancer
Patient-derived organoid (PDO) platforms to facilitate clinical decision making
Advancing cancer research through organoid technology
Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells
Stratifying esophago-gastric cancer treatment using a patient-derived organoid-based threshold
The application of patient-derived organoid in the research of lung cancer
Establishment of experimental salivary gland cancer models using organoid culture and patient-derived xenografting
Screening drug effects in patient‐derived cancer cells links organoid responses to genome alterations
Screening drug effects in patient‐derived cancer cells links organoid responses to genome alterations
Cancer research using organoid technology
Cancer research using organoid technology
A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions
Role of immune-checkpoint LAG3 as a biomarker finding tool in patient-derived organoid cultures of breast cancer